Roivant Sciences Ltd.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ROIV
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Find out what a historical investment in Roivant Sciences Ltd. would be worth today using our ROIV stock calculator.
$14.73B
-
0.00%
681
$21.33
$20.53
$0.00
$21.35
$8.73
Ready to start your investing journey with Stake?
Open an accountROIV FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ROIV
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ROIV
on Stake
Buy ROIV from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ROIV from only US$10 with fractional shares
